Our mission
To develop and implement recommendations that will improve the impact, quality and efficiency of clinical trials, leading to more rapid, lower cost and higher quality evaluation of healthcare interventions in Australia.
Our vision
To act as a platform for all stakeholder voices to come together and continually improve the clinical trials field in Australia, enabling efficient and effective, patient-centred, clinical trials.
News
Joint Position Statement
Electronic Signatures and Clinical Trial Research Agreement execution in Australia CT:IQ together with Medicines Australia (MA), Medical Technology Association of Australia (MTAA) and AusBiotech have released a joint position statement confirming that eSignatures can be used to execute clinical trial research agreements (CTRAs) in Australia. Read the statement below or access Joint Position Statement [PDF: […]